Polygenic scores link to atherosclerosis and ischemic heart disease in Russian populations
Genetic markers help predict heart disease risk for Russian men and women
This meta-analysis review examines genetic predictors of atherosclerosis, ischemic heart disease, and myocardial infarction in a Russian pop…
A large study found specific genes linked to cholesterol levels in Russian people. These genetic scores can help doctors check heart disease…
TCM and probiotics may offer a promising direction for future precision prevention and management of coronary heart disease
Traditional Chinese medicine and probiotics may help manage coronary heart disease
This narrative review discusses the potential role of traditional Chinese medicine and probiotics in coronary heart disease. The authors not…
A review suggests traditional Chinese medicine and probiotics might offer a new path for managing coronary heart disease, though more proof …
Acute kidney function decline timing predicts mortality and heart failure outcomes in hospitalized patients
Acute kidney function decline raises heart failure risk after 7 days
An analysis of EVEREST trial data reveals that acute kidney function decline at seven and fourteen days significantly increases mortality an…
In hospitalized heart failure patients, worsening kidney function at 7 and 14 days linked to higher risks of death or hospitalization.
Left Atrial Strain predicts major cardiovascular events with HR 0.91 in general population
Left Atrial Strain Predicts Heart Events in Patients With Heart Disease
This systematic review and meta-analysis of 13,156 patients found that Left Atrial Strain predicts major cardiovascular events. The analysis…
A large analysis shows that left atrial strain helps predict major heart events in people with various heart conditions, offering new insigh…
LBBAP shows lower mortality and hospitalization versus biventricular pacing in CRT
Meta-analysis links Left bundle branch area pacing to lower death risk in heart failure patients
A meta-analysis of 5,605 patients found LBBAP significantly reduced all-cause mortality and heart failure hospitalizations compared to BiVP,…
A large review suggests Left bundle branch area pacing may lower death and hospitalization risks compared to standard pacing for heart failu…
Lung ultrasound-guided decongestion reduces HF hospitalization and mortality risk in heart failure patients compared to standard care
Lung Ultrasound Guides Heart Failure Treatment, Cuts Hospitalizations
This systematic review and meta-analysis evaluated lung ultrasound-guided decongestion versus standard of care in 1095 heart failure patient…
Using lung ultrasound to guide heart failure treatment cut hospitalizations and deaths by 28% in a review of 1095 patients.
Lower VExUS grades predict reduced in-hospital mortality in acute heart failure patients
Low VExUS Scores Linked to Lower Death Risk in Heart Failure Patients
This Bayesian random-effects meta-analysis evaluated the VExUS score in patients hospitalized with acute heart failure. The analysis found s…
Patients with lower VExUS scores faced much lower in-hospital death rates compared to those with higher scores.
Structural cerebral abnormality prevalence rises from 23.1% prenatally to 50.3% postoperatively in isolated congenital heart disease
One in five babies with heart defects shows brain changes before surgery
This systematic review and meta-analysis evaluates structural cerebral abnormalities in fetuses and children with isolated congenital heart …
A large review found that structural brain issues appear in many children with heart defects, rising sharply after surgery.
Pre-transplant VAD support shows no survival benefit but increases stroke risk in pediatric heart transplant recipients
Pre-transplant VAD support does not improve long-term survival for pediatric heart transplant patients
This systematic review and meta-analysis evaluated pre-transplant ventricular assist device support versus no support in pediatric heart tra…
Using a temporary heart pump before transplant did not lower death risk for children, but it did increase the chance of a stroke after surge…
Astragalus Granule plus Western medicine ranked best for overall clinical efficacy in heart failure
Adding Astragalus-based medicines to standard heart failure treatment improves outcomes in this review
This systematic review and network meta-analysis evaluated oral traditional Chinese medicines containing Astragalus alone or in combination …
A large review of heart failure patients found that adding specific traditional Chinese medicines to standard Western treatment improved ove…
Remote monitoring algorithms predict heart failure events, may reduce hospitalizations
Remote monitoring may help predict heart failure events and reduce hospital stays
This review examines remote monitoring of cardiac implantable electronic devices for heart failure. Multiparametric algorithms like HeartLog…
A review suggests remote monitoring of heart devices could predict heart failure events and lower hospital visits, though real-world use fac…
Serum resistin levels rise progressively with worsening severity of coronary heart disease and acute myocardial infarction in this meta-analysis
High blood resistin levels linked to heart disease severity in large analysis
A network meta-analysis of 9,169 subjects reveals that serum resistin levels increase stepwise as coronary heart disease severity worsens. W…
A large network meta-analysis found that higher serum resistin levels are linked to worse coronary heart disease and acute heart attacks.
Questions about Heart Failure
Are SGLT2 inhibitors effective for treating heart failure with mildly reduced ejection fraction?
Yes, SGLT2 inhibitors are effective for treating heart failure with mildly reduced ejection fraction, reducing heart failure hospitalizations and improving outcomes.
Full answer →Does finerenone help patients with heart failure with mildly reduced ejection fraction?
Yes, finerenone reduces cardiovascular death and worsening heart failure events in patients with heart failure with mildly reduced ejection fraction, based on a network meta-analysis and the FINEARTS-HF trial.
Full answer →Can erythropoiesis-stimulating agents help adults with chronic heart failure and anaemia?
Erythropoiesis-stimulating agents (ESAs) reduce total heart failure hospitalizations and improve exercise tolerance in adults with chronic heart failure and anaemia, but do not lower mortality risk.
Full answer →Do alternative loop diuretics reduce hospitalizations for patients with chronic heart failure?
No, alternative loop diuretics (torsemide, azosemide, piretanide) do not reduce hospitalizations compared to furosemide in chronic heart failure, based on a systematic review of 23 trials.
Full answer →What are the main themes in coping experiences for chronic heart failure patients and caregivers?
Coping experiences for CHF patients and caregivers center on differing views of illness, emotional exhaustion, strained relationships, and a need for support to find new meaning.
Full answer →Does taking Qishen Yiqi dropping pills plus Western medicine improve chronic heart failure efficacy?
A 2024 trial found that adding Qishen Yiqi dropping pills to standard Western medicine improved clinical effectiveness and heart function in chronic heart failure patients.
Full answer →Does having higher levels of EPA in my blood increase my risk of ischemic heart disease?
Higher EPA levels may slightly increase ischemic heart disease risk, according to genetic studies, but the evidence is not definitive.
Full answer →What side effects or benefits did levosimendan show for patients with acute heart failure?
Levosimendan improves symptoms and heart function in acute heart failure, but can cause hypotension and tachycardia; benefits may vary by BMI.
Full answer →